Biotechnology Industry Market Research & Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
11 votes

Global Biotechnology Industry


The global biotechnology industry is forecast to exceed $320 billion by 2015, reports Global Industry Analysts. Market growth is fuelled by economic recovery, increased R&D funding, government initiatives and biotechnology used in agriculture and medical sciences. Developing nations, particularly China and India, are becoming major markets in the fields of agricultural and industrial biotechnology.


The economic crisis negatively impacted the biotechnology market, and brought about revenue declines in the US and the EU as a result of limited capital inflows and the delay or cancellation of projects. The market has entered a phase of recovery, with many large biotechnology outfits generating revenue thanks to new cost-savings and efficiency measures.


Industry funding is on the rise on the back of more favorable economic conditions, though this funding is concentrated in a small number of larger outfits. Smaller companies are still struggling to raise R&D funds. The situation is likely to improve as venture capitalists exercise greater caution in seeking more secure investment options.


Key Market Segments


  • Biological Therapy - The biotechnology industry was further segmented in 2011, steered away from its traditional drug focus and into other fields, including cleantech and chemical manufacturing. BCC Research points to the focus on funding in low-possibility-of-success (POS) areas, such as antineoplastic and immunomodulating agents over other fields with greater success potential such as dermatology or acute diseases.


  • Genetic Testing - Genetic testing represents an important market if we consider diagnosis as the key to better quality healthcare. This segment involves testing for chromosome, protein and gene abnormality or changes linked with inherited medical conditions. The global genetic testing industry is in a period of strong growth, fuelled by rising numbers of genetic disorders, better awareness and an aging population. The market was worth $1.5 billion in 2010, reports RNCOS.


  • The world genetic testing market is expected to reach $4 billion by 2015. Genetic testing for cancer is likely to experience one of the highest growth rates, receiving particular interest from the private sector and the scientific community at large. Direct-to-consumer genetic testing is a market segment that is likely to take off, with many new outfits on the market. Market shapers include 23andme and deCODE.


  • Biopharmaceuticals - Global enzyme demand is expected to grow, with the market expected to exceed $7.5 billion in 2010, according to Freedonia. The majority of markets are forecast to record yearly growth in of more than 5%, except for biofuel production and certain other smaller industrial enzyme segments. Regional growth rates will be highest in markets like the Africa/Mideast region, and Central and South America. Growth will be comparatively lower in established economies such as the US and the EU. Enzyme demand in North America will be negatively impacted by a slow switch over to biomass-based biofuel production. EU enzyme demand will be negatively impacted by the EU debt crisis.



Regional Market Share


The US dominates the global biotechnology industry, followed by developed EU nations such as Germany, Spain, France and the UK, reports Global Industry Analysts. Developing nations like China and India are likely to record strong growth in agricultural and industrial biotechnology industries due to rising income levels and population. Both countries are playing an increasingly significant role in the biotech drugs market on the back of relatively low-cost investment and a high level of expertise.



Market Outlook


Growth in the global biotechnology industry will be driven by improving healthcare infrastructure and increasing private-sector interest in information technology, according to Global Industry Analysts. There will likely be increasing merger and acquisitions activity over the coming years, driven by blockbuster drug patent expiration and healthcare regulations put in place to control costs. Smaller outfits will likely divest their businesses to larger outfits, or lean on in-licensing collaborations and partnerships with more financially secure outfits due to capital limitations.


Technological advancements, increasingly strict regulatory policies, public awareness and intellectual property are among the factors that will positively affect the biotechnology sector. Biotechnology applications will continue to increase, with agricultural, environmental sciences, medical, health and food sectors major end-use domains.


Biotech investments will continue to be aimed at new drug and therapy discoveries, led by specializations such as oncology, inflammation and cardiology. Therapeutic categories, including hormone treatment and diabetes, will receive increased attention from biotech drug companies in response to rising treatment demand in these sectors.



Leading Industry Associations offers immediate download access to top market reports & statistics on the Biotechnology Industry from trusted sources.
1-10 of about 2 800 reports

Global Biotechnology Industry Forecast

  • September 2013
    15 pages
  • Biotechnology  

    Cereal Producti  


  • World  


View report >

Biotechnology Analysis in the US

  • October 2014
    47 pages
  • Life Sciences  

    Life Sciences  

  • United States  

    North America  

View report >

Biotechnology Industry in Europe

  • July 2014
    234 pages
  • Biotechnology  

  • Europe  


View report >

Biotechnology Industry in the UK and Norway Forecast

  • January 2014
    6 pages
  • Biotechnology  

  • United Kingdom  


View report >

Biotechnology Industry in Canada Forecast

  • June 2013
    6 pages
  • Biotechnology  

  • Canada  

View report >

Biotechnology Analysis in India

  • July 2013
    13 pages
  • Biotechnology  

  • India  

View report >

Biotechnology Industry in China

  • March 2014
    59 pages
  • R d  

  • China  


    United States  

View report >

Biotechnology Supply in South Korea

  • January 2014
    5 pages
  • Biotechnology  


  • South Korea  

    United States  

View report >

Biotechnology Industry in Singapore

  • January 2014
    11 pages
  • Genetically Mod  


  • Singapore  

    United States  

View report >

Biotechnology Markets in Australia

  • July 2013
    9 pages
  • Biotechnology  

  • Australia  

View report >

Search in Biotechnology Industry (About 2 800 reports)
Topics under Biotechnology

Parent industry:  Life Sciences

Related markets: Protein, Dna, Biotech, Enzyme, Genetic, Gmo, Antibody, Cytokine, Biosimilar, Biomarker, Cell Therapy, Gm Crop

About 2 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 15 000)

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

  • $ 15 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy ...

Opticas Gmo-chile

January 2015 $ 9 141


January 2015 $ 9 141

Digital Pcr Market Research Pcr Reaction Market, Targ ...

November 2014 $ 7 000

U.s. Orthopedic Biomaterials Market

January 2015 $ 6 995

Glyphsoate China Monthly Report 1412

December 2014 $ 6 912

Global Markets For Implantable Biomaterials

January 2015 $ 6 650

Biologic Therapeutic Drugs: Technologies And Global Mar ...

January 2015 $ 6 650

Antibody Drugs: Technologies And Global Markets

January 2015 $ 6 650

Renal Biomarkers: Technologies And Global Markets

January 2015 $ 6 650

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.